Actively Recruiting
Comparison of Eleveld PKPD Model-Guided Dosing Versus Standard Weight-Based Dosing of Remimazolam During General Anesthesia in Elective Non-Cardiac Surgery
Led by Seoul National University Hospital · Updated on 2026-09-29
68
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of an individualized dosing strategy using the Eleveld pharmacokineticpharmacodynamic PKPD model for remimazolam in adults undergoing elective non-cardiac surgery with general anesthesia. This randomized, controlled trial aims to determine if the Eleveld model-guided dosing can reduce eye-opening time at surgery end compared to standard weight-based dosing, while maintaining appropriate anesthesia depth and stable heart and blood pressure levels. Participants are randomly assigned to one of two groups the Experimental Group receives remimazolam doses calculated by the Eleveld model through a web-based calculator, while the Control Group receives standard weight-based dosing with a loading dose of 9 mgkgh until loss of consciousness, followed by maintenance doses of 1-2 mgkgh. Both groups undergo general anesthesia with continuous monitoring of anesthesia depth using a Bispectral Index BIS sensor. Throughout the study, participants are monitored for time to eye-opening after stopping remimazolam, total drug doses used, and hemodynamic stability. Other assessments include measuring the time to loss of consciousness, incidence of heart rate and blood pressure changes, need for rescue drugs like flumazenil, and postoperative complications such as delirium and nausea. The study expects to complete by May 2027, with participants involved during surgery and immediate recovery periods.
CONDITIONS
Brief Title
Efficacy and Safety of Eleveld PK/PD Model-based Dosing During General Anesthesia
Research Team
H
Hansol Kim, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here